date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-17-18,"Acorda Third Quarter 2018 Update: Webcast/Conference Call Scheduled for October 31, 2018",Business Wire
Oct-23-18,Centene's (CNC) Earnings and Revenues Top Estimates in Q3,Zacks
Oct-31-18,Edited Transcript of ACOR earnings conference call or presentation 31-Oct-18 12:30pm GMT,Thomson Reuters StreetEvents
Oct-31-18,Acorda Therapeutics Inc (ACOR) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Acorda Therapeutics (ACOR) Q3 Earnings and Revenues Beat Estimates,Zacks
Oct-31-18,Acorda: 3Q Earnings Snapshot,Associated Press
Oct-31-18,Acorda Provides Financial and Pipeline Update for Third Quarter 2018,Business Wire
Nov-01-18,"Acorda (ACOR) Q3 Earnings Top Estimates, Ampyra Sales View Up",Zacks
Nov-08-18,"Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Nov-08-18,Acorda to Present at Stifel 2018 Healthcare Conference,Business Wire
Nov-13-18,Edited Transcript of ACOR earnings conference call or presentation 31-Oct-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-15-18,Acorda Down More Than 30% in the Past 3 Months: Here's Why,Zacks
Nov-27-18,Should You Worry About Acorda Therapeutics Incs (NASDAQ:ACOR) CEO Pay?,Simply Wall St.
Dec-11-18,Here's Why Acorda Therapeutics Shares Sunk 15% Today,Motley Fool
Dec-14-18,Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?,Insider Monkey
Dec-17-18,"Acorda Therapeutics PDUFA Date, Pipeline Review and Third Quarter Highlights",ACCESSWIRE
Dec-19-18,Acorda to Present at the 37th Annual J.P. Morgan Healthcare Conference,Business Wire
Dec-24-18,"Why Mindbody, New Gold, and Acorda Therapeutics Jumped Today",Motley Fool
Dec-24-18,Biotech Stock Flies After FDA Approves Parkinson's Treatment,Investor's Business Daily
Dec-24-18,Acorda Rises 9.7 Percent After FDA Gives Nod for Parkinson's Therapy,Bloomberg
Dec-24-18,Acorda Gets FDA Approval for Parkinson's Disease Drug Inbrija,Zacks
Dec-24-18,Acorda Therapeutics' Inbrija Parkinson's disease treatment gets FDA OK,MarketWatch
Dec-24-18,ADDING MULTIMEDIA Acorda Therapeutics Announces FDA Approval of INBRIJA (levodopa inhalation powder),Business Wire
Dec-26-18,"Company News For Dec 26, 2018",Zacks
Dec-26-18,"Acorda's Prospects Remain Dubious Despite Inbrija Approval, Says Bearish Raymond James",Benzinga
Dec-26-18,"Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal",Zacks
Dec-26-18,Biotech News Driving These Companies,ACCESSWIRE
Jan-07-19,Myriad Genetics (MYGN) Catches Eye: Stock Jumps 6.9%,Zacks
Jan-07-19,Acorda Provides 2018 Highlights and 2019 Guidance at J.P. Morgan Healthcare Conference,Business Wire
Jan-09-19,Mirati Therapeutics (MRTX) Catches Eye: Stock Jumps 5.4%,Zacks
Jan-10-19,Acorda (ACOR) Plans to Launch Inbrija in Q1: What to Expect,Zacks
Jan-14-19,ASLAN's Varlitinib Fails to Meet Endpoint in Phase II Study,Zacks
Jan-14-19,Apellis Pharmaceuticals (APLS) in Focus: Stock Moves 7.1% Higher,Zacks
Jan-15-19,Nabriva Therapeutics (NBRV) Jumps: Stock Rises 6.7%,Zacks
Jan-17-19,Acorda Announces The Lancet Neurology Publication of Phase 3 Data for INBRIJA (levodopa inhalation powder),Business Wire
Jan-22-19,Vertex's Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids,Zacks
Jan-22-19,Aerpio (ARPO) Jumps: Stock Rises 7.8%,Zacks
Jan-24-19,Vertex Terminates COO Ian Smith on Code of Conduct Violation,Zacks
Jan-29-19,"Have Insiders Been Selling Acorda Therapeutics, Inc. (NASDAQ:ACOR) Shares?",Simply Wall St.
